Markus Aly

5.5k total citations · 2 hit papers
52 papers, 1.5k citations indexed

About

Markus Aly is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Markus Aly has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 10 papers in Rheumatology. Recurrent topics in Markus Aly's work include Prostate Cancer Diagnosis and Treatment (36 papers), Prostate Cancer Treatment and Research (34 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Markus Aly is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (36 papers), Prostate Cancer Treatment and Research (34 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Markus Aly collaborates with scholars based in Sweden, United States and United Kingdom. Markus Aly's co-authors include Henrik Grönberg, Tobias Nordström, Martin Eklund, Jan Adolfsson, Mark Clements, Lars Egevad, Olof Akre, Fredrik Wiklund, Fredrik Jäderling and Stefan Carlsson and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Markus Aly

49 papers receiving 1.5k citations

Hit Papers

Prostate cancer screening in men aged 50–69 years (STHLM3... 2015 2026 2018 2022 2015 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Aly Sweden 17 1.2k 259 221 208 200 52 1.5k
Charlotte F. Kweldam Netherlands 19 1.4k 1.2× 136 0.5× 212 1.0× 449 2.2× 259 1.3× 35 1.7k
Tony Crispino United States 11 1.5k 1.3× 321 1.2× 279 1.3× 245 1.2× 235 1.2× 16 1.7k
Charlotte Becker Sweden 25 1.0k 0.9× 193 0.7× 217 1.0× 129 0.6× 216 1.1× 46 1.7k
Varagur Venkatesan Canada 22 1.6k 1.4× 358 1.4× 448 2.0× 152 0.7× 453 2.3× 47 2.4k
Allison Steigler Australia 18 1.5k 1.3× 280 1.1× 250 1.1× 125 0.6× 176 0.9× 50 1.8k
Simpa S. Salami United States 18 1.2k 1.0× 166 0.6× 184 0.8× 262 1.3× 266 1.3× 82 1.4k
David S. Lamb New Zealand 15 1.4k 1.2× 232 0.9× 181 0.8× 120 0.6× 156 0.8× 40 1.6k
Robert F. Hoedemaeker Netherlands 26 1.6k 1.3× 445 1.7× 434 2.0× 433 2.1× 209 1.0× 46 2.0k
Keen‐Hun Tai Australia 12 1.4k 1.2× 192 0.7× 176 0.8× 115 0.6× 144 0.7× 23 1.6k
William C. Allsbrook United States 19 854 0.7× 223 0.9× 223 1.0× 248 1.2× 85 0.4× 33 1.4k

Countries citing papers authored by Markus Aly

Since Specialization
Citations

This map shows the geographic impact of Markus Aly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Aly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Aly more than expected).

Fields of papers citing papers by Markus Aly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Aly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Aly. The network helps show where Markus Aly may publish in the future.

Co-authorship network of co-authors of Markus Aly

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Aly. A scholar is included among the top collaborators of Markus Aly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Aly. Markus Aly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eklund, Martin, Markus Aly, Mark Clements, et al.. (2025). Data Resource Profile: STHLM0, the Stockholm Prostate Cancer Diagnostics Register. International Journal of Epidemiology. 54(3). 1 indexed citations
2.
Kwok, Kelvin H. M., et al.. (2025). Characterization of treatment patterns and outcomes in muscle-invasive bladder cancer patients in Sweden. Scandinavian Journal of Urology. 60. 108–114.
3.
Zelić, Renata, Gustaf Edgren, Matteo Bottai, et al.. (2024). Risk of Venous Thromboembolic Events After Surgery for Cancer. JAMA Network Open. 7(2). e2354352–e2354352. 8 indexed citations
6.
Lantz, Anna, Ugo Giovanni Falagario, Fredrik Jäderling, et al.. (2023). Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer. European Urology Open Science. 51. 89–94. 1 indexed citations
7.
Zelić, Renata, Gustaf Edgren, Matteo Bottai, et al.. (2023). Risk of Postoperative Ischemic Stroke and Myocardial Infarction in Patients Operated for Cancer. Annals of Surgical Oncology. 31(3). 1739–1748. 3 indexed citations
8.
Aly, Markus, et al.. (2023). Association between early mobilisation after abdominal cancer surgery and postoperative complications. European Journal of Surgical Oncology. 49(9). 106943–106943. 2 indexed citations
9.
Møller, Axel, Klaus Schwamborn, Janet Hoogstraate, et al.. (2022). Travel vaccines are strongly associated to reduced mortality in prostate cancer patients - a real effect or residual confounding?. Vaccine. 40(27). 3797–3801. 1 indexed citations
10.
Stattin, Pär, et al.. (2021). The 90‐day cause‐specific mortality after radical prostatectomy: a nationwide population‐based study. British Journal of Urology. 129(3). 318–324. 2 indexed citations
11.
Nordström, Tobias, Martin Bergman, Lars Egevad, et al.. (2021). Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms. European Urology Open Science. 24. 11–16. 3 indexed citations
13.
Aly, Markus, et al.. (2019). Objectively measured mobilisation is enhanced by a new behaviour support tool in patients undergoing abdominal cancer surgery. European Journal of Surgical Oncology. 45(10). 1847–1853. 26 indexed citations
14.
Beckmann, Kerri, Netty Kinsella, Henrik Olsson, et al.. (2019). Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?. BMC Urology. 19(1). 73–73. 2 indexed citations
15.
Jäderling, Fredrik, Olof Akre, Markus Aly, et al.. (2018). Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery. Prostate Cancer and Prostatic Diseases. 22(3). 391–398. 29 indexed citations
16.
Ström, Peter, Tobias Nordström, Markus Aly, et al.. (2018). The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential. European Urology. 74(2). 204–210. 70 indexed citations
17.
Nordström, Tobias, Wolfgang Picker, Markus Aly, et al.. (2017). Detection of Prostate Cancer Using a Multistep Approach with Prostate-specific Antigen, the Stockholm 3 Test, and Targeted Biopsies: The STHLM3 MRI Project. European Urology Focus. 3(6). 526–528. 12 indexed citations
18.
Nordström, Tobias, Olof Akre, Markus Aly, Henrik Grönberg, & Martin Eklund. (2017). Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer. Prostate Cancer and Prostatic Diseases. 21(1). 57–63. 155 indexed citations
19.
Karlsson, Robert, Markus Aly, Mark Clements, et al.. (2012). A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk. European Urology. 65(1). 169–176. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026